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Abstract: 
The benzimidazole starting material 5-(1H-benzo[d]imidazol-2-yl)-4,7-dimethoxybenzofuran-
6-ol (2)was  synthesized. The  Mannich bases 3a-k  were formed using formaldehyde and primary or 
secondary amines.(2) was subjected to Mannich reaction using 1,4-phenylenediamine or piperazine to 
lead to the 1,4-disubstituted benzenes 4a or 1,4-disubstituted piperazines 4b. 
The compounds were screen for their antimicrobial activities  
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Introduction 
 Benzimidazole derivatives are of wide interest because of their diverse biological activity and 
clinical applications. Several promising antitumor active agents were found to contain the 
benzimidazole ring system(1-11). They were found to exert their antitumor activity by acting mainly as 
topoisomerases inhibitors (12-13). Benzimidazoles belonging to the fused heterocyclic system prepared 
from amino acids are associated with diverse pharmaceutical activities such as antibacterial(14), 
insecticidal(15), fungicidal(16), antimicrobial(17), antagonist(18), anthelmintic(19-21) and anti-
inflamonatary(22) etc. also Benzofuran derivatives posses a wide range of biological activities. They 
have been reported to possess antimicrobial(23-26), antitumour(27, 28), anti-inflammatory(29) activity etc. 
Hence it was though interesting to prepare the combined molecule having benzimidazole-benzofurane 
with expected biological activity.  
Chemistry 
The benzimidazole starting material 5-(1H-benzo[d]imidazol-2-yl)-4,7-dimethoxybenzofuran-
6-ol (2) was synthesized using Philips' (30) method starting from o-phenylenediamine and  6-hydroxy-
4,7-dimethoxybenzofuran-5-carboxylic acid (1)  
The Mannich bases 3a-k were formed by the reaction of compound 2 with formaldehyde and 
4-chloro-2-nitroaniline or 4-fluoroaniline, 2,6-dichloroanine, n-propylamine, dimethylamine, 
ethylamine, isopropylamine, piperidine, 2-aminobenzoic acid, or 2-hydroxyaniline respectively.(c.f. 
scheme 1). 
 When( 2) was subjected to Mannich reaction using 1,4-phenylenediamine or piperazine led to 
the 1,4-disubstituted benzenes 4a or 1,4-disubstituted piperazines 4b.(c.f. scheme 2). 
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Scheme 1: 
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3a, R= 4-chloro2-nitrophenyl 
b, R= 4-chlorophenyl 
c, R= 4-flourophenyl 
d, R= 2,6-dichlorophenyl 
e, R=  n-propyl 
f, R= dimethyl 
g, R= ethyl 
h, R= isopropyl 
i, R= piperidyl 
j, R=  2-carboxyphenyl 
k, R=  2-hydroxyphenyl 
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Scheme 2: 
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4a, R=1,4-diaminophenyl 
b, R=piperazinyl            
 
Experimental 
NMR of the synthesized compounds were not performed because the great difficulty in 
solubility
Table1: Spectral data of compounds 2 , 3a-k, 4a,b 
No. IR (KBr) υmax/cm-1 MS, m/z (%) m.p. Color 
2 
 
3389 (br. NH & OH), 2939, 
2842 (aliph. C-H 
stretching), 1660 (C=N), 
1623 (C=C), 1592 (C=C) 
 
328 (M+H2O), 310 (M), 309 (M-1), 
280 (M-HCHO), 245 (base peak), (M-
HCHO-H2O-NH3) 
 
240⁰C Black 
3a 
 
3614 (OH), 3263(OH & 
NH), 2943, 2839 (aliph. C-
H), 1620(C=N), 1508, 1481 
(C=C), 920 (C-Cl), 806 (C-
NO2) 
 
495 (M), 497 (M+2), 456 (M-NO+1), 
172 (C6H4ClN2O2), 155 (171-16-1) 
 
>350 
⁰C 
Dark 
brown 
3b 
 
 413 (M-HCl-H), 393 (413-18), 367, 
389, 319, 281, 42 (base peak) 
 
>350 
⁰C 
Dark 
brown 
3c 
 
3421 (OH & NH), 2921 (C-
H stretching), 1640 (C=N), 
1618 (C=C), 1482. 
 
439 (M), 440 (M+1), 438, 437, 383, 
355 (base peak), 239, 211 
 
>350 
⁰C 
Dark 
brown 
3d 
 
3407 (OH & NH), 2939, 
2840 (C-H stretching), 1650 
(C=N), 1611 (C=C), 1482, 
678 (C-Cl) 
 
483 (M), 442 (483-Cl), 417 (447-
HCHO), 389 (417-CO), 63 (base peak) 
 
>350 
⁰C 
Dark 
brown 
3e 
 
3409 (NH & OH), 2939, 
2841 (aliph. C-H 
367 (M-CH3+1), 339(M-n-propyl+1), 
294 (M-n-propyl-NH-CH2-17+1), 276, 
>350 
⁰C 
Dark 
brown 
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Biological Activity 
The antimicrobial activity of  material against  E. coli was investigated as a pathogenic  
bacteria . Bacteriological Tests were performed in lysogeny broth (LB) (  Bertani, G. (2004)) medium 
on solid agar plates and in liquid systems. The materials  were shown to be an effective bactericide or 
bacteriostatic . The results show effect of 32 materials on growth of pathogenic bacteria by  Growth 
measurements methods  
stretching), 1655 (C=N), 
1617 (C=C) 
 
265 
 
3f 
 
3418 (NH & OH), 2938 
(aliph. C-H stretching), 
1660 (C=N), 1616,1482 
(C=C) 
 
 
369 (M+2), 368(M+1), 367(M), 
353(M-CH2), 119 (base peak). 
>350 
⁰C 
Dark 
brown 
3g 
 
3407, 3224 (NH & OH), 
2939 (aliph. C-H 
stretching), 1655 (C=N), 
1614, 1513 (C=C). 
 
368 (M-CH3+2H+), 277, 204, 190, 57 
(base peak) 
 
>350 
⁰C 
Reddish 
brown 
3h 3412, (NH & OH), 2971, 
2937, 2846 (aliph. C-H 
stretching), 1640 (C=N), 
1616, 1500 (C=C). 
 
382 (M+1), 381 (M), 369 (M-CH2 +1), 
286( base peak), 204, 189, 161, 119… 
>350 
⁰C 
Dark 
brown 
3i  407 (M), 311 (M-piperidyl-2), 78, 63( 
base peak). 
>350 
⁰C 
Dark 
brown 
3j 3402, (OH, NH3+), 2937, 
(aliph. C-H stretching), 
1700 (shoulder C=O), 1616 
(C=N), 1612 (COO-),  
1481(C=C). 
 
460 (M+1), 459 (M), 414, 397, 249, 
121 (base peak) 
>350 
⁰C 
Dark 
brown 
3k 
 
3614 (OH), 3139 (NH & 
OH), 2958, 2750, 2592 
(aliph. C-H stretching), 
1616 (C=N) 1523, 1446 
(C=C). 
 
401 (M), 254, 244, 230 (base peak), 
122,109…… 
 
>350 
⁰C 
Dark 
brown 
4a 
 
3409 (NH & OH), 2943, 
2839 (aliph. C-H 
stretching), 1660 (C=N), 
1620, 1512 (C=C) 
 
752 (M), 108 (base peak) 
 
>350 
⁰C 
Dark 
brown 
4b 
 
3394 (NH & OH), 2947 
(aliph. C-H stretching), 
1635 (C=N), 1508 (C=C) 
 
730 (M+1), 729 (M), 672 (M-2CHO), 
654 (M-2CHO-18), 627 (M-2CHO-18-
HCN), 132 (
N
N
CH2 +1), 193 (
OHO
OCH3
OCH3 ), 112 (base peak), 84 
(piperazine) 
 
>350 
⁰C 
Dark 
brown 
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Material and Methods 
Bactericidal test 
Escherichia coli strain was grown on (lb) broth  for 24 hour were cultured on 20 ml on 50 ml falcon  
of lb broth  by add 10 microliter from culture and supplemented with 0.3  gram from tested   materials 
. material- free lb broth cultured under the same conditions were used as a control > the falcons was 
incubation  in shaker incubator  for 24 hour in 30 c at 150 rpm   >>>the table  show O.D (optical 
density) for control and  other treatments at wave 600  
Counting plates  
The  treatments was cultured after 24 hour  incubation  on lb agar plates by pour plate method 
to counting survival  bacteria  to indicator  the effect of  material on bacteria. The culture was diluted 
to 10-7 and then put 50 microliter on plate and then incubated for  24 hour and 30 c   
Results and Discussion 
 The table show the Comparison between the control and other treatment on optical dencity 
and Counting plates and it showe the materials 3b was Active growth and materials 3a and 4b was 
made Percentage of death 66 %  ,and material 3f was made percentage of death 33%. 
Table 2: O.D for culture supplemented with 10 materials .and show plat counting result 
a 
Material 
 
O.D 
 
 
Percentage of 
death  % 
 
Plate count 
Cont 0.6 0 1205 cell 
2 0.5 16 1020 
3a  0.2 66 400 
3b 0.6 X 1170 
3e 0.5 16 1172 
3f 0.4 33 900 
3g 0.5 16 1100 
3i 0.6 0 1205 
3j 0.5 16 1006 
4a 0.5 16 1010 
4b 0.2 66 204 
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